Aeterna Zentaris (NASDAQ:AEZS) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.09 and traded as high as $3.47. Aeterna Zentaris shares last traded at $3.35, with a volume of 1,390 shares trading hands.

Analyst Ratings Changes

Separately, Wall Street Zen assumed coverage on shares of Aeterna Zentaris in a report on Monday, May 19th. They issued a “sell” rating for the company.

Aeterna Zentaris Trading Up 0.8%

The company has a 50-day moving average price of $3.47 and a two-hundred day moving average price of $3.09. The stock has a market cap of $6.01 million, a P/E ratio of -0.23 and a beta of 1.55.

Aeterna Zentaris Company Profile

Aeterna Zentaris Inc, a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis.